Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Serious adverse drug events reported to the FDA: analysis of the FDA Adverse Event Reporting System 2006–2014 database.

Sonawane KB, Cheng N, Hansen RA. Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database. J Manag Care Spec Pharm. 2018;24(7):682-690. doi:10.18553/jmcp.2018.24.7.682.

Save
Print
October 17, 2018
Sonawane KB, Cheng N, Hansen RA. J Manag Care Spec Pharm. 2018;24(7):682-690.
View more articles from the same authors.

This retrospective study reviewed serious and fatal adverse drug events (ADEs) reported to the Food and Drug Administration between 2006 and 2014. Over the 9-year study period, the number of serious ADEs reported doubled and a small number of medications accounted for a significant number of serious and fatal ADEs.

Save
Print
Cite
Citation

Sonawane KB, Cheng N, Hansen RA. Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database. J Manag Care Spec Pharm. 2018;24(7):682-690. doi:10.18553/jmcp.2018.24.7.682.